Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1489 Articles

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Jan 13, 2020 at 6:45 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Jon C. Ogg | Jan 11, 2020 at 7:05 AM EST

20 Biopharma Stocks for Huge Upside Potential in 2020

Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 7, 2020 at 2:58 PM EST

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.

Jon C. Ogg | Jan 6, 2020 at 12:45 PM EST

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

Chris Lange | Jan 2, 2020 at 10:25 AM EST

The Top Biopharma Events to Watch in 2020

Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch…

Paul Ausick | Dec 31, 2019 at 6:55 AM EST

5 Top (and Bottom) Dow Performers in 2019

Here's a look at the five best- and five worst-performing stocks among the Dow Jones industrial average this past year.

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 26, 2019 at 6:40 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.

Chris Lange | Dec 23, 2019 at 11:00 AM EST

The Top Biopharma Calendar Events to Watch Going Into 2020

Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to…

Jon C. Ogg | Dec 13, 2019 at 12:25 PM EST

Meet the Preliminary 2020 Dogs of the Dow

One theme that investors love in good times and in bad is dividend investing. One strategy that has been around…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 11, 2019 at 7:10 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 24 25 26 27 28 … 100

Pfizer : PFE

All Pfizer Articles

Short Sellers Shy Away From Big Pharma

The 5 Most Shorted Dow Stocks

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

Why Wealthy Retirees Are Spending Their 401(k) First and Letting Social Security Compound to Age 70

Forget ASML: As Post-June 5 Volatility Shakes High-Beta Tech, This Dividend-Paying Chip Index Is a No-Brainer Buy

SpaceX Raises Record $75 Billion in Historic IPO, Reaches $1.8 Trillion Valuation

Why Wealthy Retirees Are Spending Their 401(k) First and Letting Social Security Compound to Age 70

'Citibank and Amex Have Screwed an 85-Year-Old Widow': Dave Ramsey on $45,000 in Credit Card Debt With No Assets

Move Over, New York! Why Texas Is Becoming ‘America’s New Center of Gravity’

Intel Is Up 8% Today: Is It Outperforming Other Chip Stocks Like AMD and NVIDIA?

Pfizer : PFE

All Pfizer Articles

Short Sellers Shy Away From Big Pharma

The 5 Most Shorted Dow Stocks

20 Biopharma Stocks for Huge Upside Potential in 2020

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

5 Top (and Bottom) Dow Performers in 2019

Big Pharma Short Sellers Get Selective

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

Stock Market Live June 12, 2026: S&P 500 (SPY) Green on End of War Hopes

Live Nasdaq Composite: Markets Hold Breath on Mideast Deal, SpaceX IPO Launch

Why Wealthy Retirees Are Spending Their 401(k) First and Letting Social Security Compound to Age 70

Forget ASML: As Post-June 5 Volatility Shakes High-Beta Tech, This Dividend-Paying Chip Index Is a No-Brainer Buy

SpaceX Raises Record $75 Billion in Historic IPO, Reaches $1.8 Trillion Valuation

Featured Reads

Why Wealthy Retirees Are Spending Their 401(k) First and Letting Social Security Compound to Age 70

'Citibank and Amex Have Screwed an 85-Year-Old Widow': Dave Ramsey on $45,000 in Credit Card Debt With No Assets